V. Kapsimali, M. Kanakis, G. Vaiopoulos, and P. Kaklamanis, Etiopathogenesis of Beh??et's disease with emphasison the role of immunological aberrations, Clinical Rheumatology, vol.51, issue.suppl 30, pp.1211-1216, 2010.
DOI : 10.1007/s10067-010-1491-6

E. Birtas-atesoglu, N. Inanc, S. Yavuz, T. Ergun, and H. Direskeneli, Serum levels of free heat shock protein 70 and anti-HSP70 are elevated in Behçet's disease, Clin Exp Rheumatol, vol.26, issue.4, pp.96-104, 2009.

M. Smet and A. Ramadan, Circulating antibodies to inducible heat shock protein 70 in patients with uveitis, Ocular Immunology and Inflammation, vol.12, issue.2, pp.85-92, 2001.
DOI : 10.1076/ocii.9.2.85.3973

H. Yasuoka, Y. Yamaguchi, N. Mizuki, T. Nishida, Y. Kawakami et al., Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behçet's disease and HLA-B51, Clin. Exp. Rheumatol. Aoû, vol.26, issue.4, pp.59-63, 2008.

S. Sögüt, E. Aydin, H. Elyas, N. Aksoy, H. Ozyurt et al., The activities of serum adenosine deaminase and xanthine oxidase enzymes in Behcet's disease, Clinica Chimica Acta, vol.325, issue.1-2, pp.133-138, 2002.
DOI : 10.1016/S0009-8981(02)00278-4

K. Köse, C. Yazici, and O. A??io?lu, The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Beh??et???s disease, Clinical Biochemistry, vol.34, issue.2, pp.125-129, 2001.
DOI : 10.1016/S0009-9120(01)00190-4

K. Erkiliç, C. Evereklioglu, M. Cekmen, A. Ozkiris, F. Duygulu et al., Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Beh??et's disease: original contributions/clinical and laboratory investigations, Mediators of Inflammation, vol.12, issue.2, 2003.
DOI : 10.1080/0962935031000097754

F. Canpolat, M. Unver, F. Eskio?lu, S. Kösebalaban, and S. Durmazlar, Serum and erythrocyte adenosine deaminase activities in patients with Beh??et's disease, International Journal of Dermatology, vol.279, issue.9, pp.1053-1056, 2006.
DOI : 10.1111/j.1365-4632.2006.02892.x

M. Calis, F. Ates, C. Yazici, K. Kose, M. Kirnap et al., Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Beh??et???s disease, Rheumatology International, vol.128, issue.6, 2005.
DOI : 10.1007/s00296-005-0612-z

E. Eksioglu-demiralp, H. Direskeneli, A. Kibaroglu, S. Yavuz, T. Ergun et al., Neutrophil activation in Behçet's disease, Clin. Exp. Rheumatol, vol.19, issue.5, pp.19-24, 2001.

E. Alpsoy, C. Zouboulis, and G. Ehrlich, Mucocutaneous Lesions of Beh??et's Disease, Yonsei Medical Journal, vol.48, issue.4, pp.573-585, 2007.
DOI : 10.3349/ymj.2007.48.4.573

T. Ergun, O. Gürbüz, J. Harvell, J. Jorizzo, and W. White, The histopathology of pathergy: a chronologic study of skin hyperreactivity in Beh??et's disease, International Journal of Dermatology, vol.41, issue.12, 1998.
DOI : 10.1046/j.1365-4362.1998.00474.x

N. Akdeniz, M. Esrefoglu, M. Kele?, A. Karakuzu, and M. Atasoy, Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease, Ann. Acad. Med. Singap, vol.33, issue.5, pp.596-599, 2004.

Y. Bardak and B. Arido?an, The demonstration of serum interleukin 6???8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Beh??et???s disease with ocular involvement, Ocular Immunology and Inflammation, vol.6, issue.1, pp.53-58, 2004.
DOI : 10.3109/08830189709116847

C. Evereklioglu, H. Er, Y. Türköz, and M. Cekmen, Serum levels of TNF-??, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Beh??et's disease, Mediators of Inflammation, vol.11, issue.2, pp.87-93, 2002.
DOI : 10.1080/09629350220131935

K. Hamzaoui, A. Hamzaoui, F. Guemira, M. Bessioud, M. Hamza et al., Cytokine profile in Beh??et's disease patients, Scandinavian Journal of Rheumatology, vol.133, issue.15, pp.205-210, 2002.
DOI : 10.1080/030097402320318387

F. Neves, S. Carrasco, C. Goldenstein-schainberg, C. Gonçalves, and S. De-mello, Neutrophil hyperchemotaxis in Beh??et???s disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses, Clinical Rheumatology, vol.164, issue.4 Suppl.38, 2009.
DOI : 10.1007/s10067-009-1261-5

K. Ozoran, N. Dügün, A. Gürler, H. Tutkak, and G. Tokgöz, Plasma von Willebrand Factor, Tissue Plasminogen Activator, Plasminogen Activator Inhibitor, and Antithrombin III Levels in Beh??et's Disease, Scandinavian Journal of Rheumatology, vol.28, issue.6, pp.376-382, 1995.
DOI : 10.3109/03009749509095184

B. Schulz, J. Pruessmeyer, T. Maretzky, A. Ludwig, C. Blobel et al., ADAM10 Regulates Endothelial Permeability and T-Cell Transmigration by Proteolysis of Vascular Endothelial Cadherin, Circulation Research, vol.102, issue.10, pp.1192-201, 2008.
DOI : 10.1161/CIRCRESAHA.107.169805

E. Dejana, F. Orsenigo, and M. Lampugnani, The role of adherens junctions and VE-cadherin in the control of vascular permeability, Journal of Cell Science, vol.121, issue.13, pp.2115-2122, 2008.
DOI : 10.1242/jcs.017897

U. Gotsch, E. Borges, R. Bosse, E. Böggemeyer, M. Simon et al., VE-cadherin antibody accelerates neutrophil recruitment in vivo, J. Cell. Sci, vol.110, pp.583-588, 1997.

D. Maschio, A. Zanetti, A. Corada, M. Rival, Y. Ruco et al., Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions, The Journal of Cell Biology, vol.135, issue.2, pp.497-510, 1996.
DOI : 10.1083/jcb.135.2.497

F. Cand, L. Pelletier, I. Vilgrain, and . Patent, Circulating VE-Cadherin as a predictive marker of sensitivity or resistance to anti-tumoral treatment, and improved method for the detection of soluble proteins, 2008.

B. Hermant, S. Bibert, E. Concord, B. Dublet, M. Weidenhaupt et al., Identification of Proteases Involved in the Proteolysis of Vascular Endothelium Cadherin during Neutrophil Transmigration, Journal of Biological Chemistry, vol.278, issue.16, pp.14002-14014, 2003.
DOI : 10.1074/jbc.M300351200

Z. Habibagahi, M. Habibagahi, and M. Heidari, Raised concentration of soluble form of vascular endothelial cadherin and IL-23 in sera of patients with Behçet's disease. Mod Rheumatol, Avr, vol.20, issue.2, pp.154-159, 2010.

T. Soeki, Y. Tamura, H. Shinohara, K. Sakabe, Y. Onose et al., Elevated Concentration of Soluble Vascular Endothelial Cadherin Is Associated With Coronary Atherosclerosis, Circulation Journal, vol.68, issue.1, pp.1-5, 2004.
DOI : 10.1253/circj.68.1

M. Corada, F. Liao, M. Lindgren, M. Lampugnani, F. Breviario et al., Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability, Blood, vol.97, issue.6, pp.1679-1684, 2001.
DOI : 10.1182/blood.V97.6.1679

F. Davatchi, S. Abdollahi, B. Shahram, F. Nadji, A. Chams-davatchi et al., Validation of the International Criteria for Beh??et???s disease (ICBD) in Iran, International Journal of Rheumatic Diseases, vol.229, issue.11, pp.55-60, 2010.
DOI : 10.1111/j.1756-185X.2009.01455.x

B. Chumpitazi, L. Bouillet, M. Drouet, L. Kuhn, J. Garin et al., Biological autoimmunity screening in hepatitis C patients by anti-HepG2 lysate and anti-heat shock protein 70.1 autoantibodies, European Journal of Clinical Microbiology & Infectious Diseases, vol.18, issue.2, pp.137-146, 2008.
DOI : 10.1007/s10096-008-0599-y

URL : https://hal.archives-ouvertes.fr/hal-00320221

M. Navarro, R. Cervera, J. Font, J. Reverter, J. Monteagudo et al., Review : Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance, Lupus, vol.22, issue.6, pp.521-526, 1997.
DOI : 10.1177/096120339700600608

A. Aydìntug, G. Tokgöz, D. Cruz, D. Gürler, A. Cervera et al., P 160 Antibodies to endothelial cells in patients with Beh??et's disease, La Revue de M??decine Interne, vol.14, 1993.
DOI : 10.1016/S0248-8663(05)82462-2

R. Cervera, M. Navarro, A. López-soto, M. Cid, J. Font et al., Antibodies to endothelial cells in Behcet's disease: cell-binding heterogeneity and association with clinical activity., Annals of the Rheumatic Diseases, vol.53, issue.4, pp.265-267, 1994.
DOI : 10.1136/ard.53.4.265

K. Tsutsui, M. Hasegawa, M. Takata, and K. Takehara, Increased plasma granulocyte elastase levels in Behçet's disease, J. Rheumatol. Fév, vol.25, issue.2, pp.326-328, 1998.

O. De?er, A. Orem, N. Akyol, S. Bahadir, and S. Yildirmis, Polymorphonuclear leukocyte elastase levels in patients with Beh??et's disease, Clinica Chimica Acta, vol.236, issue.2, pp.129-134, 1995.
DOI : 10.1016/0009-8981(95)06033-A

O. Florey, M. Johns, O. Esho, J. Mason, and D. Haskard, Antiendothelial cell antibodies mediate enhanced leukocyte adhesion to cytokine-activated endothelial cells through a novel mechanism requiring cooperation between Fc{gamma}RIIa and CXCR1, Blood. Mai, vol.1109, issue.29, pp.3881-3889, 2007.

C. Belizna, A. Duijvestijn, M. Hamidou, C. Tervaert, and J. , Antiendothelial cell antibodies in vasculitis and connective tissue disease, Annals of the Rheumatic Diseases, vol.65, issue.12, pp.1545-1550, 2006.
DOI : 10.1136/ard.2005.035295

S. Garnier-raveaud, Y. Usson, F. Cand, M. Robert-nicoud, J. Verdetti et al., Identification of Membrane Calcium Channels Essential for Cytoplasmic and Nuclear Calcium Elevations Induced by Vascular Endothelial Growth Factor in Human Endothelial Cells, Growth Factors, vol.28, issue.1, pp.35-48, 2001.
DOI : 10.1007/BF02222186

URL : https://hal.archives-ouvertes.fr/hal-00192530

D. Gulino, E. Delachanal, E. Concord, Y. Genoux, B. Morand et al., Alteration of Endothelial Cell Monolayer Integrity Triggers Resynthesis of Vascular Endothelium Cadherin, Journal of Biological Chemistry, vol.273, issue.45, pp.29786-29793, 1998.
DOI : 10.1074/jbc.273.45.29786

M. Corada, M. Mariotti, G. Thurston, K. Smith, R. Kunkel et al., Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo, Proceedings of the National Academy of Sciences, vol.96, issue.17, pp.9815-9820, 1999.
DOI : 10.1073/pnas.96.17.9815

P. Ozta?, N. Lortlar, M. Polat, A. N. Omero?lu, S. Basman et al., Caspase-9 expression is increased in endothelial cells of active Beh??et's disease patients, International Journal of Dermatology, vol.12, issue.2, pp.172-176, 2007.
DOI : 10.1111/j.1365-4632.2007.03209.x

N. Tsukada, Y. Tanaka, and N. Yanagisawa, Autoantibodies to brain endothelial cells in the sera of patients with human T-lymphotropic virus type I associated myelopathy and other demyelinating disorders, Journal of the Neurological Sciences, vol.90, issue.1, pp.33-42, 1989.
DOI : 10.1016/0022-510X(89)90043-9

R. Souza, L. Lage, C. Goldesntein-schainberg, A. Macedo, S. Carrasco et al., Anti-endothelial cell antibodies and central nervous system involvement in Behçet's disease. Clinics (Sao Paulo), Déc, vol.62, issue.6, pp.685-690, 2007.